Patent intelligence · US
US 2005215524
Methods and compositions for improving photodynamic therapy through administration of lipids
Methods and compositions for improving photodynamic therapy through administration of lipids
Patent details — US 2005215524
- Jurisdiction
- US
- Status
- expired
- Grant date
- Sep 29, 2005
- Expiration
- Sep 24, 2025
- Applicant
- CERAMOPTEC IND INC [DE]
- CPC classes
- A61K 31/ 409 A I, A61K 31/ 555 A I, A61K 31/ 685 A I, A61K/31409
Quick answer
US 2005215524 (Methods and compositions for improving photodynamic therapy through administration of lipids) is held by CERAMOPTEC IND INC [DE]. Status: expired. Granted Sep 29, 2005. Expires Sep 24, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CERAMOPTEC IND INC [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 409 A I, A61K 31/ 555 A I, A61K 31/ 685 A I, A61K/31409, A61K/31555, A61K/31685
More from CERAMOPTEC IND INC [DE]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2005215524?
US 2005215524 (Methods and compositions for improving photodynamic therapy through administration of lipids) is held by CERAMOPTEC IND INC [DE]. Status: expired. Granted Sep 29, 2005. Expires Sep 24, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2005215524?
CERAMOPTEC IND INC [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2005215524 expire?
Our index shows an expiration date of Sep 24, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.